Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Evaluation of total adiponectin, adipocyte fatty acid binding protein and fibroblast growth factor 21 levels in individuals with metabolic syndrome

D. Novotný, H. Vaverková, D. Karásek, J. Lukeš, L. Slavík, P. Malina, J. Orság

. 2014 ; 63 (2) : 219-228.

Language English Country Czech Republic

Document type Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't

Although many studies have investigated the relationships of several adipokines to metabolic syndrome (MetS), the interrelationships of adiponectin (ADP), adipocyte fatty acid binding protein (A-FABP) and fibroblast growth factor 21 (FGF 21) have not been described in detail. We examined 209 asymptomatic dyslipidemic patients divided into MetS+ (n=73) and MetS- (n=136) groups. The aim of study was to evaluate the relationships between observed adipokines, to compare the levels of total ADP, A-FABP and FGF 21 in individuals with and without MetS, and to elucidate the relationships of individual adipokines to lipid parameters, markers of insulin resistance and endothelial hemostatic markers in these groups. In MetS+ group, we found the independent positive association ADP with A-FABP (beta=0.4888, p=0.0382), A-FABP with FGF 21 (beta=0.3811, p=0.0002) and von Willebrand factor (beta=0.4502, p=0.0013), and FGF 21 with A-FABP (beta=0.4422, p=0.0002). Our study has confirmed the well-established risk profile of subjects with MetS, although clinically asymptomatic. MetS+ patients had also lower levels of ADP and higher levels of A-FABP and FGF 21. Our study evaluated the interrelationships of ADP, A-FABP and FGF 21 in asymptomatic dyslipidemic subjects with diagnosis of MetS. Especially strong association between A-FABP and FGF 21 needs to be clarified in further studies.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15003893
003      
CZ-PrNML
005      
20150129124535.0
007      
ta
008      
150128s2014 xr f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.932602 $2 doi
035    __
$a (PubMed)24397811
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Novotný, Dalibor, $d 1965-2015 $7 xx0041926 $u Department of Clinical Biochemistry, University Hospital Olomouc, Olomouc, Czech Republic
245    10
$a Evaluation of total adiponectin, adipocyte fatty acid binding protein and fibroblast growth factor 21 levels in individuals with metabolic syndrome / $c D. Novotný, H. Vaverková, D. Karásek, J. Lukeš, L. Slavík, P. Malina, J. Orság
520    9_
$a Although many studies have investigated the relationships of several adipokines to metabolic syndrome (MetS), the interrelationships of adiponectin (ADP), adipocyte fatty acid binding protein (A-FABP) and fibroblast growth factor 21 (FGF 21) have not been described in detail. We examined 209 asymptomatic dyslipidemic patients divided into MetS+ (n=73) and MetS- (n=136) groups. The aim of study was to evaluate the relationships between observed adipokines, to compare the levels of total ADP, A-FABP and FGF 21 in individuals with and without MetS, and to elucidate the relationships of individual adipokines to lipid parameters, markers of insulin resistance and endothelial hemostatic markers in these groups. In MetS+ group, we found the independent positive association ADP with A-FABP (beta=0.4888, p=0.0382), A-FABP with FGF 21 (beta=0.3811, p=0.0002) and von Willebrand factor (beta=0.4502, p=0.0013), and FGF 21 with A-FABP (beta=0.4422, p=0.0002). Our study has confirmed the well-established risk profile of subjects with MetS, although clinically asymptomatic. MetS+ patients had also lower levels of ADP and higher levels of A-FABP and FGF 21. Our study evaluated the interrelationships of ADP, A-FABP and FGF 21 in asymptomatic dyslipidemic subjects with diagnosis of MetS. Especially strong association between A-FABP and FGF 21 needs to be clarified in further studies.
650    _2
$a adiponektin $x krev $7 D052242
650    _2
$a dospělí $7 D000328
650    _2
$a asymptomatické nemoci $7 D058070
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a dyslipidemie $x krev $x diagnóza $7 D050171
650    _2
$a proteiny vázající mastné kyseliny $x krev $7 D050556
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fibroblastové růstové faktory $x krev $7 D005346
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a metabolický syndrom $x krev $x diagnóza $7 D024821
650    _2
$a lidé středního věku $7 D008875
655    _2
$a hodnotící studie $7 D023362
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vaverková, Helena, $d 1942- $7 nlk20000083882 $u Third Department of Internal Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Karásek, David $7 stk2007415300 $u Third Department of Internal Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Lukeš, Jiří $7 xx0070976 $u Department of Clinical Biochemistry, University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Slavík, Luděk $7 xx0081908 $u Department of HematoOncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
700    1_
$a Malina, Pavel $7 xx0158428 $u Department of Clinical Biochemistry, Hospital Písek, Písek, Czech Republic
700    1_
$a Orság, Jiří $7 xx0229430 $u Third Department of Internal Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 63, č. 2 (2014), s. 219-228
856    41
$u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20150128 $b ABA008
991    __
$a 20150129124729 $b ABA008
999    __
$a ok $b bmc $g 1060953 $s 886648
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 63 $c 2 $d 219-228 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK118 $a Pubmed-20150128

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...